ID   PTN14_HUMAN             Reviewed;        1187 AA.
AC   Q15678; Q5VSI0;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 2.
DT   15-FEB-2017, entry version 164.
DE   RecName: Full=Tyrosine-protein phosphatase non-receptor type 14;
DE            EC=3.1.3.48;
DE   AltName: Full=Protein-tyrosine phosphatase pez;
GN   Name=PTPN14; Synonyms=PEZ, PTPD2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Mammary carcinoma;
RX   PubMed=7733990; DOI=10.1006/bbrc.1995.1591;
RA   Smith A.L., Mitchell P.J., Shipley J., Gusterson B.A., Rogers M.V.,
RA   Crompton M.R.;
RT   "Pez: a novel human cDNA encoding protein tyrosine phosphatase- and
RT   ezrin-like domains.";
RL   Biochem. Biophys. Res. Commun. 209:959-965(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=10934049;
RA   Wadham C., Gamble J.R., Vadas M.A., Khew-Goodall Y.;
RT   "Translocation of protein tyrosine phosphatase Pez/PTPD2/PTP36 to the
RT   nucleus is associated with induction of cell proliferation.";
RL   J. Cell Sci. 113:3117-3123(2000).
RN   [6]
RP   FUNCTION.
RX   PubMed=12808048; DOI=10.1091/mbc.E02-09-0577;
RA   Wadham C., Gamble J.R., Vadas M.A., Khew-Goodall Y.;
RT   "The protein tyrosine phosphatase Pez is a major phosphatase of
RT   adherens junctions and dephosphorylates beta-catenin.";
RL   Mol. Biol. Cell 14:2520-2529(2003).
RN   [7]
RP   FUNCTION.
RX   PubMed=17893246; DOI=10.1083/jcb.200705035;
RA   Wyatt L., Wadham C., Crocker L.A., Lardelli M., Khew-Goodall Y.;
RT   "The protein tyrosine phosphatase Pez regulates TGFbeta, epithelial-
RT   mesenchymal transition, and organ development.";
RL   J. Cell Biol. 178:1223-1235(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-486, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   FUNCTION, INTERACTION WITH FLT4, AND INVOLVEMENT IN CHATLY.
RX   PubMed=20826270; DOI=10.1016/j.ajhg.2010.08.008;
RA   Au A.C., Hernandez P.A., Lieber E., Nadroo A.M., Shen Y.M.,
RA   Kelley K.A., Gelb B.D., Diaz G.A.;
RT   "Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic
RT   function and choanal development in humans.";
RL   Am. J. Hum. Genet. 87:436-444(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-591; SER-594 AND
RP   SER-642, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   SUBCELLULAR LOCATION, INDUCTION, FUNCTION, INTERACTION WITH YAP1; CUL2
RP   AND LRR1, AND UBIQUITINATION.
RX   PubMed=22948661; DOI=10.1101/gad.192955.112;
RA   Wang W., Huang J., Wang X., Yuan J., Li X., Feng L., Park J.I.,
RA   Chen J.;
RT   "PTPN14 is required for the density-dependent control of YAP1.";
RL   Genes Dev. 26:1959-1971(2012).
RN   [14]
RP   INVOLVEMENT IN HTT, AND FUNCTION.
RX   PubMed=22233626; DOI=10.1038/ncomms1633;
RA   Benzinou M., Clermont F.F., Letteboer T.G., Kim J.H., Espejel S.,
RA   Harradine K.A., Arbelaez J., Luu M.T., Roy R., Quigley D.,
RA   Higgins M.N., Zaid M., Aouizerat B.E., van Amstel J.K., Giraud S.,
RA   Dupuis-Girod S., Lesca G., Plauchu H., Hughes C.C., Westermann C.J.,
RA   Akhurst R.J.;
RT   "Mouse and human strategies identify PTPN14 as a modifier of
RT   angiogenesis and hereditary haemorrhagic telangiectasia.";
RL   Nat. Commun. 3:616-616(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-594, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   INTERACTION WITH YAP1, FUNCTION, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=22525271; DOI=10.1038/onc.2012.147;
RA   Liu X., Yang N., Figel S.A., Wilson K.E., Morrison C.D., Gelman I.H.,
RA   Zhang J.;
RT   "PTPN14 interacts with and negatively regulates the oncogenic function
RT   of YAP.";
RL   Oncogene 32:1266-1273(2013).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 886-1187.
RX   PubMed=16534812; DOI=10.1002/prot.20958;
RA   Barr A.J., Debreczeni J.E., Eswaran J., Knapp S.;
RT   "Crystal structure of human protein tyrosine phosphatase 14 (PTPN14)
RT   at 1.65-A resolution.";
RL   Proteins 63:1132-1136(2006).
RN   [18]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLU-159 AND PRO-360.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Protein tyrosine phosphatase which may play a role in
CC       the regulation of lymphangiogenesis, cell-cell adhesion, cell-
CC       matrix adhesion, cell migration, cell growth and also regulates
CC       TGF-beta gene expression, thereby modulating epithelial-
CC       mesenchymal transition. Mediates beta-catenin dephosphorylation at
CC       adhesion junctions. Acts as a negative regulator of the oncogenic
CC       property of YAP, a downstream target of the hippo pathway, in a
CC       cell density-dependent manner. May function as a tumor suppressor.
CC       {ECO:0000269|PubMed:10934049, ECO:0000269|PubMed:12808048,
CC       ECO:0000269|PubMed:17893246, ECO:0000269|PubMed:20826270,
CC       ECO:0000269|PubMed:22233626, ECO:0000269|PubMed:22525271,
CC       ECO:0000269|PubMed:22948661}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate. {ECO:0000255|PROSITE-ProRule:PRU10044}.
CC   -!- SUBUNIT: Interacts with FLT4; the interaction is enhanced by
CC       stimulation with VEGFC. Interacts (via PPxY motifs) with YAP1 (via
CC       WW domains); this interaction leads to the cytoplasmic
CC       sequestration of YAP1 and inhibits its transcriptional co-
CC       activator activity. {ECO:0000269|PubMed:20826270,
CC       ECO:0000269|PubMed:22525271, ECO:0000269|PubMed:22948661}.
CC   -!- INTERACTION:
CC       P46937:YAP1; NbExp=6; IntAct=EBI-1237156, EBI-1044059;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton
CC       {ECO:0000250}. Nucleus. Note=Translocation into the nucleus is
CC       associated with induction of cell proliferation. Partially
CC       colocalized with actin filaments at the plasma membrane.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- INDUCTION: Up-regulated at protein level by cell density. However,
CC       at the mRNA level remains the same regardless of the status of
CC       cell density. {ECO:0000269|PubMed:22948661}.
CC   -!- PTM: Ubiquitinated by the ECS (Elongin BC-CUL2/5-SOCS-box
CC       protein)/LRR1 E3 ligase complex and subsequently targeted to
CC       proteasomal degradation. {ECO:0000269|PubMed:22948661}.
CC   -!- DISEASE: Choanal atresia and lymphedema (CHATLY) [MIM:613611]: A
CC       disease characterized by posterior choanal atresia and lymphedema.
CC       Additional features are a high-arched palate, hypoplastic nipples,
CC       and mild pectus excavatum. {ECO:0000269|PubMed:20826270}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry. A homozygous deletion in PTPN14 predicted to result in
CC       frameshift and premature truncation, has been shown to be the
CC       cause of choanal atresia and lymphedema in one family.
CC   -!- DISEASE: Note=Influence clinical severity of hereditary
CC       haemorragic telagiectasia (HHT). {ECO:0000269|PubMed:22233626}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Non-receptor class subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PTPN14ID41913ch1q32.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X82676; CAA57993.1; -; mRNA.
DR   EMBL; AL929236; CAH70919.1; -; Genomic_DNA.
DR   EMBL; AL445305; CAH70919.1; JOINED; Genomic_DNA.
DR   EMBL; AL592216; CAH70919.1; JOINED; Genomic_DNA.
DR   EMBL; AL603838; CAH70919.1; JOINED; Genomic_DNA.
DR   EMBL; AL603838; CAH72982.1; -; Genomic_DNA.
DR   EMBL; AL445305; CAH72982.1; JOINED; Genomic_DNA.
DR   EMBL; AL592216; CAH72982.1; JOINED; Genomic_DNA.
DR   EMBL; AL929236; CAH72982.1; JOINED; Genomic_DNA.
DR   EMBL; AL445305; CAH73027.1; -; Genomic_DNA.
DR   EMBL; AL592216; CAH73027.1; JOINED; Genomic_DNA.
DR   EMBL; AL603838; CAH73027.1; JOINED; Genomic_DNA.
DR   EMBL; AL929236; CAH73027.1; JOINED; Genomic_DNA.
DR   EMBL; AL592216; CAH73479.1; -; Genomic_DNA.
DR   EMBL; AL445305; CAH73479.1; JOINED; Genomic_DNA.
DR   EMBL; AL603838; CAH73479.1; JOINED; Genomic_DNA.
DR   EMBL; AL929236; CAH73479.1; JOINED; Genomic_DNA.
DR   EMBL; CH471100; EAW93351.1; -; Genomic_DNA.
DR   EMBL; BC101754; AAI01755.1; -; mRNA.
DR   EMBL; BC104803; AAI04804.1; -; mRNA.
DR   CCDS; CCDS1514.1; -.
DR   PIR; JC4155; JC4155.
DR   RefSeq; NP_005392.2; NM_005401.4.
DR   RefSeq; XP_016857430.1; XM_017001941.1.
DR   UniGene; Hs.193557; -.
DR   UniGene; Hs.688910; -.
DR   PDB; 2BZL; X-ray; 1.65 A; A=886-1187.
DR   PDBsum; 2BZL; -.
DR   ProteinModelPortal; Q15678; -.
DR   SMR; Q15678; -.
DR   BioGrid; 111748; 43.
DR   DIP; DIP-38131N; -.
DR   IntAct; Q15678; 17.
DR   STRING; 9606.ENSP00000355923; -.
DR   BindingDB; Q15678; -.
DR   ChEMBL; CHEMBL3317332; -.
DR   DEPOD; Q15678; -.
DR   iPTMnet; Q15678; -.
DR   PhosphoSitePlus; Q15678; -.
DR   BioMuta; PTPN14; -.
DR   DMDM; 209572662; -.
DR   EPD; Q15678; -.
DR   MaxQB; Q15678; -.
DR   PaxDb; Q15678; -.
DR   PeptideAtlas; Q15678; -.
DR   PRIDE; Q15678; -.
DR   DNASU; 5784; -.
DR   Ensembl; ENST00000366956; ENSP00000355923; ENSG00000152104.
DR   GeneID; 5784; -.
DR   KEGG; hsa:5784; -.
DR   UCSC; uc001hkk.3; human.
DR   CTD; 5784; -.
DR   DisGeNET; 5784; -.
DR   GeneCards; PTPN14; -.
DR   HGNC; HGNC:9647; PTPN14.
DR   HPA; CAB011469; -.
DR   HPA; CAB069441; -.
DR   HPA; HPA053864; -.
DR   MalaCards; PTPN14; -.
DR   MIM; 603155; gene.
DR   MIM; 613611; phenotype.
DR   neXtProt; NX_Q15678; -.
DR   OpenTargets; ENSG00000152104; -.
DR   PharmGKB; PA33989; -.
DR   eggNOG; KOG0792; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00870000136380; -.
DR   HOGENOM; HOG000115775; -.
DR   HOVERGEN; HBG053757; -.
DR   InParanoid; Q15678; -.
DR   KO; K18025; -.
DR   OMA; EKVEYSA; -.
DR   OrthoDB; EOG091G00QP; -.
DR   PhylomeDB; Q15678; -.
DR   TreeFam; TF315900; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   SIGNOR; Q15678; -.
DR   ChiTaRS; PTPN14; human.
DR   EvolutionaryTrace; Q15678; -.
DR   GeneWiki; PTPN14; -.
DR   GenomeRNAi; 5784; -.
DR   PRO; PR:Q15678; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000152104; -.
DR   CleanEx; HS_PTPN14; -.
DR   ExpressionAtlas; Q15678; baseline and differential.
DR   Genevisible; Q15678; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IMP:UniProtKB.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; IPI:UniProtKB.
DR   GO; GO:0003712; F:transcription cofactor activity; IMP:UniProtKB.
DR   GO; GO:0001946; P:lymphangiogenesis; IMP:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0006470; P:protein dephosphorylation; TAS:ProtInc.
DR   GO; GO:0046825; P:regulation of protein export from nucleus; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.80.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_3-hlx.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR019747; FERM_CS.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR018979; FERM_N.
DR   InterPro; IPR018980; FERM_PH-like_C.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR014392; Tyr_Pase_non-rcpt_typ-14/21.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   InterPro; IPR029071; Ubiquitin-rel_dom.
DR   Pfam; PF09380; FERM_C; 1.
DR   Pfam; PF00373; FERM_M; 1.
DR   Pfam; PF09379; FERM_N; 1.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PIRSF; PIRSF000934; Tyr-Ptase_nr14; 1.
DR   PRINTS; PR00935; BAND41.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM01196; FERM_C; 1.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF47031; SSF47031; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00660; FERM_1; 1.
DR   PROSITE; PS00661; FERM_2; 1.
DR   PROSITE; PS50057; FERM_3; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Cytoskeleton; Hydrolase;
KW   Nucleus; Phosphoprotein; Polymorphism; Protein phosphatase;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN         1   1187       Tyrosine-protein phosphatase non-receptor
FT                                type 14.
FT                                /FTId=PRO_0000219437.
FT   DOMAIN       21    306       FERM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00084}.
FT   DOMAIN      909   1180       Tyrosine-protein phosphatase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160}.
FT   REGION     1121   1127       Substrate binding. {ECO:0000250}.
FT   COMPBIAS    566    573       Poly-Pro.
FT   COMPBIAS    709    716       Poly-Glu.
FT   ACT_SITE   1121   1121       Phosphocysteine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00160,
FT                                ECO:0000255|PROSITE-ProRule:PRU10044}.
FT   BINDING    1079   1079       Substrate. {ECO:0000250}.
FT   BINDING    1165   1165       Substrate. {ECO:0000250}.
FT   MOD_RES     314    314       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62130}.
FT   MOD_RES     461    461       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62130}.
FT   MOD_RES     486    486       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES     591    591       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     593    593       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62130}.
FT   MOD_RES     594    594       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     642    642       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     831    831       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62130}.
FT   VARIANT     159    159       Q -> E (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035849.
FT   VARIANT     360    360       H -> P (in a breast cancer sample;
FT                                somatic mutation; dbSNP:rs112523432).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035850.
FT   VARIANT     505    505       V -> F (in dbSNP:rs12239356).
FT                                /FTId=VAR_046995.
FT   CONFLICT    392    392       H -> D (in Ref. 1; CAA57993).
FT                                {ECO:0000305}.
FT   HELIX       896    903       {ECO:0000244|PDB:2BZL}.
FT   HELIX       909    914       {ECO:0000244|PDB:2BZL}.
FT   TURN        926    929       {ECO:0000244|PDB:2BZL}.
FT   HELIX       931    933       {ECO:0000244|PDB:2BZL}.
FT   HELIX       946    948       {ECO:0000244|PDB:2BZL}.
FT   STRAND      964    972       {ECO:0000244|PDB:2BZL}.
FT   STRAND      975    982       {ECO:0000244|PDB:2BZL}.
FT   TURN        987    989       {ECO:0000244|PDB:2BZL}.
FT   HELIX       990    999       {ECO:0000244|PDB:2BZL}.
FT   STRAND     1004   1007       {ECO:0000244|PDB:2BZL}.
FT   STRAND     1011   1013       {ECO:0000244|PDB:2BZL}.
FT   STRAND     1032   1035       {ECO:0000244|PDB:2BZL}.
FT   STRAND     1038   1047       {ECO:0000244|PDB:2BZL}.
FT   STRAND     1049   1060       {ECO:0000244|PDB:2BZL}.
FT   TURN       1061   1063       {ECO:0000244|PDB:2BZL}.
FT   STRAND     1066   1074       {ECO:0000244|PDB:2BZL}.
FT   STRAND     1079   1081       {ECO:0000244|PDB:2BZL}.
FT   HELIX      1086   1103       {ECO:0000244|PDB:2BZL}.
FT   HELIX      1105   1107       {ECO:0000244|PDB:2BZL}.
FT   STRAND     1117   1125       {ECO:0000244|PDB:2BZL}.
FT   HELIX      1126   1142       {ECO:0000244|PDB:2BZL}.
FT   HELIX      1149   1157       {ECO:0000244|PDB:2BZL}.
FT   HELIX      1167   1183       {ECO:0000244|PDB:2BZL}.
SQ   SEQUENCE   1187 AA;  135261 MW;  1D22F1C8ED06C096 CRC64;
     MPFGLKLRRT RRYNVLSKNC FVTRIRLLDS NVIECTLSVE STGQECLEAV AQRLELRETH
     YFGLWFLSKS QQARWVELEK PLKKHLDKFA NEPLLFFGVM FYVPNVSWLQ QEATRYQYYL
     QVKKDVLEGR LRCTLDQVIR LAGLAVQADF GDYNQFDSQD FLREYVLFPM DLALEEAVLE
     ELTQKVAQEH KAHSGILPAE AELMYINEVE RLDGFGQEIF PVKDNHGNCV HLGIFFMGIF
     VRNRIGRQAV IYRWNDMGNI THNKSTILVE LINKEETALF HTDDIENAKY ISRLFATRHK
     FYKQNKICTE QSNSPPPIRR QPTWSRSSLP RQQPYILPPV HVQCGEHYSE THTSQDSIFH
     GNEEALYCNS HNSLDLNYLN GTVTNGSVCS VHSVNSLNCS QSFIQASPVS SNLSIPGSDI
     MRADYIPSHR HSAIIVPSYR PTPDYETVMR QMKRGILHTD SQSQSLRNLN IINTHAYNQP
     EDLVYSQPEM RERHPYTVPY GPQGVYSNKL VSPSDQRNPK NNVVPSKPGA SAISHTVSTP
     ELANMQLQGS HNYSTAHMLK NYLFRPPPPY PRPRPATSTP DLASHRHKYV SGSSPDLVTR
     KVQLSVKTFQ EDSSPVVHQS LQEVSEPLTA TKHHGTVNKR HSLEVMNSMV RGMEAMTLKS
     LHLPMARRNT LREQGPPEEG SGSHEVPQLP QYHHKKTFSD ATMLIHSSES EEEEEEAPES
     VPQIPMLREK MEYSAQLQAA LARIPNKPPP EYPGPRKSVS NGALRQDQAS LPPAMARARV
     LRHGPAKAIS MSRTDPPAVN GASLGPSISE PDLTSVKERV KKEPVKERPV SEMFSLEDSI
     IEREMMIRNL EKQKMAGLEA QKRPLMLAAL NGLSVARVSG REENRVDATR VPMDERFRTL
     KKKLEEGMVF TEYEQIPKKK ANGIFSTAAL PENAERSRIR EVVPYEENRV ELIPTKENNT
     GYINASHIKV VVGGAEWHYI ATQGPLPHTC HDFWQMVWEQ GVNVIAMVTA EEEGGRTKSH
     RYWPKLGSKH SSATYGKFKV TTKFRTDSVC YATTGLKVKH LLSGQERTVW HLQYTDWPDH
     GCPEDVQGFL SYLEEIQSVR RHTNSMLEGT KNRHPPIVVH CSAGVGRTGV LILSELMIYC
     LEHNEKVEVP MMLRLLREQR MFMIQTIAQY KFVYQVLIQF LQNSRLI
//
